Clinical Trial Update: Multi-antigen T Cell Infusion Against Neuro-oncologic Disease [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating a multi-antigen T cell infusion for brain tumors is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Neoplasms

Drugs mentioned

• Multi-antigen T cell infusion

Snippet

Sponsor: Catherine Bollard | Conditions: Brain Tumor | Phase 1 | Status: ACTIVE_NOT_RECRUITING